ā¢
LG
LGVN
Longeveron Inc. Common Stock
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
11.37M
Volume
64.62K
52W High
$1.92
52W Low
$0.49
Open
$0.00
Prev Close
$0.53
Day Range
0.00 - 0.00
About Longeveron Inc. Common Stock
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
Latest News
Longeveron Announces Closing Of Up To $17.5 Million Public Offering
Benzingaā¢Aug 11
LongeveronĀ® Presents Lomecel-Bā¢ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeonsā Society (CHSS) 51st Annual Meeting
GlobeNewswire Inc.ā¢Oct 27
Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire Inc.ā¢Sep 5
LongeveronĀ® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-Bā¢ in Mild Alzheimerās Disease at the Alzheimerās Association International ConferenceĀ® (AAIC)
GlobeNewswire Inc.ā¢Jul 28
LongeveronĀ® Announces U.S. FDA Grants Fast Track - GlobeNewswire
GlobeNewswire Inc.ā¢Jul 17
Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Benzingaā¢Jul 11
Nasdaq Gains 1%; LegalZoom Shares Slide - Benzinga
Benzingaā¢Jul 10
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Benzinga
Benzingaā¢Jul 10